{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:29:16Z","timestamp":1781152156515,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jcf.2023.08.013","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T07:25:35Z","timestamp":1698045935000},"page":"1017-1023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Stephanie E.","family":"Chiuve","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Leitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4421-7009","authenticated-orcid":false,"given":"Craig","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Rennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Lino","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Decktor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Dowd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce C","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3685-4078","authenticated-orcid":false,"given":"Drucy","family":"Borowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcf.2023.08.013_bib0001","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0884533610373772","article-title":"Nutrition treatment of deficiency and malnutrition in chronic pancreatitis: a review","volume":"25","author":"Duggan","year":"2010","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.jcf.2023.08.013_bib0002","series-title":"Patient registry 2019. Annual data report","year":"2020"},{"issue":"suppl 37","key":"10.1016\/j.jcf.2023.08.013_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/014107689909237S08","article-title":"Update on intestinal strictures","volume":"92","author":"Littlewood","year":"1999","journal-title":"J R Soc Med"},{"issue":"9","key":"10.1016\/j.jcf.2023.08.013_bib0004","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.SMJ.0000129939.14179.FE","article-title":"Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy","volume":"97","author":"Mack","year":"2004","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.jcf.2023.08.013_bib0005","doi-asserted-by":"crossref","first-page":"W73","DOI":"10.2214\/AJR.06.1589","article-title":"Fibrosing colonopathy in adults with cystic fibrosis","volume":"190","author":"Brett","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.jcf.2023.08.013_bib0006","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1099-1557(199709\/10)6:5<347::AID-PDS305>3.0.CO;2-2","article-title":"Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis","volume":"6","author":"Bakowski","year":"1997","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8889","key":"10.1016\/j.jcf.2023.08.013_bib0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(94)90817-6","article-title":"Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes","volume":"343","author":"Smyth","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jcf.2023.08.013_bib0008","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(95)70153-2","article-title":"Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee","volume":"127","author":"Borowitz","year":"1995","journal-title":"J Pediatr"},{"issue":"S22","key":"10.1016\/j.jcf.2023.08.013_bib0009","first-page":"501","article-title":"Fibrosing colonopathy (FC): retrospective analysis of U.S. cases 1995\u20131999 [abstract]","volume":"32","author":"Stevens","year":"2001","journal-title":"Pediatr Pulm"},{"issue":"6","key":"10.1016\/j.jcf.2023.08.013_bib0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00063198-200211000-00010","article-title":"Proper usage of pancreatic enzymes","volume":"8","author":"Schibli","year":"2002","journal-title":"Curr Opin Pulm Med"},{"issue":"18","key":"10.1016\/j.jcf.2023.08.013_bib0011","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199705013361803","article-title":"High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis","volume":"336","author":"FitzSimmons","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2023.08.013_bib0012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/j.1552-4604.1994.tb03981.x","article-title":"Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations","volume":"34","author":"Kraisinger","year":"1994","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jcf.2023.08.013_bib0013","series-title":"Center for Drug Evaluation and Research (CDER). Guidance for industry; exocrine pancreatic insufficiency drug products-submitting NDAs","year":"2006"},{"issue":"7","key":"10.1016\/j.jcf.2023.08.013_bib0014","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The Cystic Fibrosis Foundation Patient Registry. Design and methods of a national observational disease registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"8985","key":"10.1016\/j.jcf.2023.08.013_bib0015","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(95)91860-4","article-title":"Fibrosing Colonopathy in Cystic Fibrosis: results of a case-control study","volume":"346","author":"Smyth","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2023.08.013_bib0016","series-title":"Consensus statement: use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy","year":"1995"},{"issue":"4","key":"10.1016\/j.jcf.2023.08.013_bib0017","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcf.2017.03.005","article-title":"Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelines","volume":"16","author":"Calvo-Lerma","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2023.08.013_bib0018","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/ped.2010.0050","article-title":"Pharmacotherapy update: pancreatic enzyme products","volume":"23","author":"Hendeles","year":"2010","journal-title":"Pediatr Allerg Immunol Pulmonol"},{"key":"10.1016\/j.jcf.2023.08.013_bib0019","series-title":"Patient registry 2021 Annual data report","year":"2022"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323008809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323008809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:09:30Z","timestamp":1762031370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323008809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1569199323008809"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.08.013","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}